Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Gastric”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07273981
What this trial is testing

Zanidatamab Combined With Chemotherapy as Neoadjuvant Therapy for HER2-high Expression G/GEJC

Who this might be right for
Gastric/Gastroesophageal Junction Adenocarcinoma
Xijing Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT06764875
What this trial is testing

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

Who this might be right for
HER2-positive Gastric CancerGastroesophageal Junction Adenocarcinoma
AstraZeneca 840
Large-scale testing (Phase 3)UnknownNCT03961867
What this trial is testing

Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric Adenocarcinoma

Who this might be right for
Gastric Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 440
Not applicableStudy completedNCT03416101
What this trial is testing

Siewert Type II Esophageal Adenocarcinoma: Relationship Between Histology and Survival

Who this might be right for
Siewert Type II Adenocarcinoma of Esophagogastric Junction
University of Bologna 154
Not applicableUnknownNCT05800236
What this trial is testing

Characterisation of the Intratumoral Microbiome in Gastric Adenocarcinoma: to a Personalised Medicine

Who this might be right for
Gastric Adenocarcinoma
University Hospital, Bordeaux 20
Testing effectiveness (Phase 2)Study completedNCT03126110
What this trial is testing

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 145
Not applicableStudy completedNCT02680990
What this trial is testing

Resilience and Exercise in Advanced Cancer Treatment

Who this might be right for
Pancreatic AdenocarcinomaGastric AdenocarcinomaAdenocarcinoma of the Gastroesophageal Junction
Milton S. Hershey Medical Center 14
Not applicableStudy completedNCT03817866
What this trial is testing

Chromogranin A as Blood Marker in Cancer Patients

Who this might be right for
Gastric NeoplasmsPancreatic NeoplasmsSmall Intestinal Neoplasms+1 more
Brahms AG 175
Testing effectiveness (Phase 2)UnknownNCT04913337
What this trial is testing

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
MesotheliomaGlioblastomaRenal Cell Carcinoma+12 more
NGM Biopharmaceuticals, Inc 179
Testing effectiveness (Phase 2)UnknownNCT01798251
What this trial is testing

XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach

Who this might be right for
Gastric Cancer
Harbin Medical University 40
Testing effectiveness (Phase 2)Temporarily pausedNCT04111172
What this trial is testing

A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal AdenocarcinomaGastric Adenocarcinoma+35 more
Thomas Jefferson University 48
Early research (Phase 1)Looking for participantsNCT05365581
What this trial is testing

ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 398
Testing effectiveness (Phase 2)Study completedNCT00061932
What this trial is testing

Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+5 more
National Cancer Institute (NCI) 41
Large-scale testing (Phase 3)Study completedNCT02370498
What this trial is testing

Pembrolizumab (MK-3475) Versus Paclitaxel for Participants With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma That Progressed After Therapy With Platinum and Fluoropyrimidine (MK-3475-061/KEYNOTE-061)

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Merck Sharp & Dohme LLC 592
Early research (Phase 1)Ended earlyNCT02391038
What this trial is testing

MLN0264 in Previously Treated Asian Participants With Advanced Gastrointestinal Carcinoma or Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Guanylyl Cyclase C

Who this might be right for
Advanced Gastrointestinal CarcinomaGastroesophageal Junction AdenocarcinomaRecurrent Gastric Adenocarcinoma+4 more
Millennium Pharmaceuticals, Inc. 12
Not applicableStudy completedNCT00001240
What this trial is testing

Evaluating Patients With Abnormal Levels of Gastric Acid

Who this might be right for
AchlorhydriaGastrinomaZollinger Ellison Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not applicableNot Yet RecruitingNCT07092449
What this trial is testing

Pucotenlimab Combined With Chemotherapy as Perioperative Treatment for Locally Advanced Gastroesophageal Junction Carcinoma

Who this might be right for
Gastroesophageal JunctionGastric / Gastroesophageal Junction AdenocarcinomaNeoadjuvant Chemoimmunotherapy+1 more
Tang-Du Hospital 30
Testing effectiveness (Phase 2)UnknownNCT04442984
What this trial is testing

FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III)

Who this might be right for
Gastric Carcinoma Stage IVEsophagogastric Junction Adenocarcinoma Stage IV
Blokhin's Russian Cancer Research Center 326
Testing effectiveness (Phase 2)Looking for participantsNCT06333314
What this trial is testing

Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

Who this might be right for
Pancreatic AdenocarcinomaAmpulla of Vater CarcinomaAdrenocortical Carcinoma+5 more
UNICANCER 120
Not applicableWithdrawnNCT06702384
What this trial is testing

Molecular Analysis of Gastric and OEsophageal Cancers STudy

Who this might be right for
Adenocarcinoma EsophagusAdenocarcinoma of the StomachAdenocarcinoma - GEJ+1 more
Royal Marsden NHS Foundation Trust
Next Page